JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Agilysys
AGYS
$3.22B
| $560K | ﹤0.01% |
12,588
+1,192
| +10% | +$56.6K |
|
4577
Aprea Therapeutics
APRE
$8.42M
| $559K | ﹤0.01% |
9,741
+442
| +5% | +$39K |
|
4578
Rayonier Advanced Materials
RYAM
$570M
| $559K | ﹤0.01% |
97,918
+40,983
| +72% | +$266K |
|
4579
Uranium Energy
UEC
$5.55B
| $559K | ﹤0.01% |
167,248
+43,081
| +35% | +$166K |
|
4580
Greif Class B
GEF.B
$4.2B
| $556K | ﹤0.01% |
9,290
+4,112
| +79% | +$264K |
|
|
SKX
4581
CALL
DELISTED
Skechers
SKX
| $556K | ﹤0.01% |
12,800
-41,200
| -76% | -$1.85M |
|
4582
Aquestive Therapeutics
AQST
$533M
| $554K | ﹤0.01% |
142,368
+23,903
| +20% | +$120K |
|
4583
PUT
Vipshop
VIPS
$6.81B
| $554K | ﹤0.01% |
+66,000
| New | +$691K |
|
4584
PUT
Antero Resources
AR
$11.5B
| $553K | ﹤0.01% |
31,600
| – | – |
|
4585
Peoples Financial Services
PFIS
$714M
| $553K | ﹤0.01% |
10,484
+4,843
| +86% | +$234K |
|
|
AFIB
4586
DELISTED
Acutus Medical Inc
AFIB
| $553K | ﹤0.01% |
162,254
+154,932
| +2,116% | +$873K |
|
4587
PUT
EQT Corp
EQT
$34B
| $552K | ﹤0.01% |
25,300
+24,400
| +2,711% | +$510K |
|
4588
Veru
VERU
$46.5M
| $552K | ﹤0.01% |
9,364
+3,482
| +59% | +$266K |
|
4589
Bionano Genomics
BNGO
$13.5M
| $551K | ﹤0.01% |
307
+24
| +8% | +$64.2K |
|
4590
ProShares Ultra S&P500
SSO
$8.47B
| $551K | ﹤0.01% |
15,052
-1,056
| -7% | -$36.1K |
|
|
BGX
4591
Blackstone Long-Short Credit Income Fund
BGX
$139M
| $550K | ﹤0.01% |
37,408
-2,900
| -7% | -$43.7K |
|
4592
Citizens
CIA
$201M
| $546K | ﹤0.01% |
102,681
+37,385
| +57% | +$229K |
|
4593
Privia Health
PRVA
$2.81B
| $546K | ﹤0.01% |
21,107
+3,603
| +21% | +$89.8K |
|
4594
Alta Equipment Group
ALTG
$237M
| $545K | ﹤0.01% |
37,219
+11,156
| +43% | +$164K |
|
|
INVX
4595
Innovex International
INVX
$2.18B
| $545K | ﹤0.01% |
27,665
+1,861
| +7% | +$41K |
|
|
AIH
4596
DELISTED
Aesthetic Medical International Holdings
AIH
| $545K | ﹤0.01% |
156,529
| – | – |
|
4597
TETRA Technologies
TTI
$1.27B
| $544K | ﹤0.01% |
191,724
+93,177
| +95% | +$287K |
|
4598
DMC Global
BOOM
$155M
| $543K | ﹤0.01% |
13,689
+675
| +5% | +$26.9K |
|
4599
TriSalus Life Sciences
TLSI
$324M
| $543K | ﹤0.01% |
55,000
-195,210
| -78% | -$1.94M |
|
|
HWKZ
4600
DELISTED
Hawks Acquisition Corp
HWKZ
| $543K | ﹤0.01% |
+56,028
| New | +$544K |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.